ENZON PHARMACEUTICALS, INC. Annual Operating Income (Loss) in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Enzon Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
  • Enzon Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$325K, a 2.2% decline year-over-year.
  • Enzon Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$1.09M, a 5.51% decline year-over-year.
  • Enzon Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$1.04M, a 1.16% decline from 2022.
  • Enzon Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$1.03M, a 120% decline from 2021.
  • Enzon Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$469K, a 64.1% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$1.04M -$12K -1.16% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-20
2022 -$1.03M -$563K -120% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-20
2021 -$469K +$836K +64.1% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-16
2020 -$1.31M -$332K -34.1% Jan 1, 2020 Dec 31, 2020 10-K 2022-02-25
2019 -$973K Jan 1, 2019 Dec 31, 2019 10-K 2021-02-23
2015 $10.8M -$18M -62.5% Jan 1, 2015 Dec 31, 2015 10-K 2016-03-21
2014 $28.8M +$10.6M +58.5% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-21
2013 $18.2M +$22.1M Jan 1, 2013 Dec 31, 2013 10-K 2015-03-05
2012 -$3.97M +$12.5M +75.9% Jan 1, 2012 Dec 31, 2012 10-K 2014-03-14
2011 -$16.5M -$15.9M -2762% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-14
2010 -$575K Jan 1, 2010 Dec 31, 2010 10-K 2013-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.